Compare RJF & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RJF | GEHC |
|---|---|---|
| Founded | 1962 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 33.1B |
| IPO Year | N/A | N/A |
| Metric | RJF | GEHC |
|---|---|---|
| Price | $162.68 | $82.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $181.00 | $85.89 |
| AVG Volume (30 Days) | 1.1M | ★ 4.2M |
| Earning Date | 10-22-2025 | 10-29-2025 |
| Dividend Yield | ★ 1.23% | 0.17% |
| EPS Growth | 6.19 | ★ 32.35 |
| EPS | ★ 10.30 | 4.83 |
| Revenue | $14,015,000,000.00 | ★ $20,246,000,000.00 |
| Revenue This Year | $13.65 | $6.33 |
| Revenue Next Year | $6.45 | $4.38 |
| P/E Ratio | ★ $15.79 | $17.07 |
| Revenue Growth | ★ 9.52 | 3.51 |
| 52 Week Low | $117.57 | $57.65 |
| 52 Week High | $177.66 | $94.80 |
| Indicator | RJF | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 58.23 | 66.24 |
| Support Level | $155.16 | $79.00 |
| Resistance Level | $157.68 | $84.11 |
| Average True Range (ATR) | 3.32 | 2.21 |
| MACD | 0.78 | 0.86 |
| Stochastic Oscillator | 94.78 | 88.56 |
Raymond James Financial is a diversified financial services firm that provides wealth management, investment banking, asset management, and capital markets services to individuals, corporations, and municipalities. The firm maintains an extensive catalogue of products and services across its business lines. However, the wealth management franchise generates the bulk of its revenues and earnings through a vast network of nearly 8,800 independent and employee-affiliated advisors, who collectively manage over $1.7 trillion in client assets as of fiscal year-end 2025. While Raymond James maintains a global footprint, the company derives over 90% of its revenue, and an even larger percentage of its operating income, from the United States.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).